Upgrade to SI Premium - Free Trial

Longeveron (LGVN)

6.81 +0.23 (3.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Form 8-K Longeveron Inc. For: Aug 17 August 25, 2026 7:03 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 17 Filed by: Jhaveri Nirav S. August 25, 2026 6:05 PM - SEC Filing Form 3 Longeveron Inc. For: Aug 17 Filed by: Jhaveri Nirav S. August 25, 2026 6:00 PM - SEC Filing Form 8-K Longeveron Inc. For: Aug 20 August 24, 2026 4:15 PM - SEC Filing Longeveron sets 1-for-10 reverse stock split effective Aug. 26 August 24, 2026 4:05 PM - StreetInsider Longeveron Announces 1-for-10 Reverse Stock Split August 24, 2026 4:05 PM - Globe NewsWire Form 4 Longeveron Inc. For: Aug 19 Filed by: Blass Devin August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Lehr Paul T August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Soffer Rock August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Cann Leah Rush August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Hajjar Roger Joseph August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Paletta George A. Jr. August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Desai Arjun JJ August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Ungaro Ursula August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Hare Joshua August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Ascheim Deborah August 21, 2026 6:00 PM - SEC Filing Form 4 Longeveron Inc. For: Aug 19 Filed by: Agafonova Nataliya August 21, 2026 6:00 PM - SEC Filing Form 8-K Longeveron Inc. For: Aug 17 August 19, 2026 4:14 PM - SEC Filing Longeveron names Nirav Jhaveri as CFO August 19, 2026 4:05 PM - StreetInsider Longeveron Appoints Nirav Jhaveri as Chief Financial Officer August 19, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G/A Longeveron Inc. Filed by: INTRACOASTAL CAPITAL, LLC August 13, 2026 10:18 AM - SEC Filing Longeveron (LGVN) Misses Q2 EPS by 1c August 12, 2026 4:46 PM - StreetInsider Form 8-K Longeveron Inc. For: Aug 12 August 12, 2026 4:14 PM - SEC Filing Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update August 12, 2026 4:05 PM - Globe NewsWire Form 10-Q Longeveron Inc. For: Jun 30 August 12, 2026 4:03 PM - SEC Filing Longeveron wins $1M XPRIZE Healthspan milestone award August 11, 2026 9:05 AM - StreetInsider Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition August 11, 2026 9:05 AM - Globe NewsWire Form SCHEDULE 13G Longeveron Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC August 10, 2026 5:06 PM - SEC Filing Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026 August 3, 2026 4:05 PM - Globe NewsWire Form 8-K Longeveron Inc. For: Jul 24 July 29, 2026 4:02 PM - SEC Filing Form 3 Longeveron Inc. For: Jul 13 Filed by: Washburn Marie July 29, 2026 3:46 PM - SEC Filing Longeveron adds Dr. Deborah Ascheim to its board of directors July 23, 2026 9:15 AM - StreetInsider Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors July 23, 2026 9:15 AM - Globe NewsWire Form 3 Longeveron Inc. For: Jul 13 Filed by: Washburn Marie July 21, 2026 6:00 PM - SEC Filing Form 3 Longeveron Inc. For: Jul 02 Filed by: Desai Arjun JJ July 14, 2026 6:00 PM - SEC Filing Form 8-K Longeveron Inc. For: Jul 08 July 14, 2026 5:20 PM - SEC Filing Form 3 Longeveron Inc. For: Jul 01 Filed by: Ascheim Deborah July 13, 2026 6:00 PM - SEC Filing Form 3 Longeveron Inc. For: Jul 01 Filed by: Cann Leah Rush July 13, 2026 6:00 PM - SEC Filing Longeveron shares Phase 2a laromestrocel data at AAIC 2026 July 13, 2026 7:06 AM - StreetInsider Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P July 13, 2026 7:05 AM - Globe NewsWire Form S-8 Longeveron Inc. July 10, 2026 4:47 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 06 Filed by: Hare Joshua July 8, 2026 6:00 PM - SEC Filing Form 8-K Longeveron Inc. For: Jul 08 July 8, 2026 4:06 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 01 Filed by: Willard Stephen H July 6, 2026 8:55 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 01 Filed by: Locklear Lisa July 6, 2026 8:55 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 01 Filed by: Agafonova Nataliya July 6, 2026 8:55 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 01 Filed by: Blass Devin July 6, 2026 8:55 PM - SEC Filing Form 4 Longeveron Inc. For: Jul 01 Filed by: Lehr Paul T July 6, 2026 8:55 PM - SEC Filing Form 8-K Longeveron Inc. For: Jun 30 July 6, 2026 4:31 PM - SEC Filing Longeveron names Marie Washburn as CFO, effective July 13 July 6, 2026 4:05 PM - StreetInsider Longeveron® Appoints Marie Washburn as Chief Financial Officer July 6, 2026 4:05 PM - Globe NewsWire Longeveron stem cell therapy data to be presented at 2026 AAIC June 18, 2026 9:20 AM - StreetInsider New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AA June 18, 2026 9:20 AM - Globe NewsWire Longeveron receives SME status from European Medicines Agency June 9, 2026 9:20 AM - StreetInsider Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA) June 9, 2026 9:20 AM - Globe NewsWire Full Article List